Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Mats Wåhlin AB (”MWAB”)
Mandate

Vinge has advised Eleda Infra Services Group (“Eleda”) on the acquisition of Mats Wåhlin AB (”MWAB”)

March 08, 2022 Banking and Finance M&A Corporate Crime & Compliance Commercial Agreements Employment and Benefits

MWAB is based in Stockholm and specialises in diving and maritime constructions in confined and contaminated environments for customers in the public sector, as well as private contractors. The company has over 40 years’ experience and a turnover of approximately SEK 35 million on an annual basis.

Vinge’s team consisted primarily of partner Christina Kokko and associates Manne Bergström and Carl Fredrik Wachtmeister (M&A), Ellen Åkerdahl Flygt (M&A and Banking & Finance), Isak Willborg (Agreements), Elin Broman (Employment), Tove Tullberg (Compliance), Sara Dahlros Sköld and Elin Kollin (VDR-assistants).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026